Smith & Nephew

Select your country

Advanced Search

  • Home
  • About Us
  • Innovation
  • Corporate Responsibility
  • Investor Centre
  • News & Media
  • Careers
  • Home
  • Innovation
  • Key Products
  • Clinical Therapies
  • SUPARTZ
  • Home >
  • Innovation >
  • Key Products >
  • Clinical Therapies >
  • SUPARTZ
  • EXOGEN
  • DUROLANE
  • SUPARTZ
  • Print
  • e-mail

Email this page

close
  1. Mandatory fields are marked with an asterisk [*].

    Tell us who you want to send your mail to Fill in your email details

    Note: Smith & Nephew does not collect or make use of the email addresses or names provided here. They are only used to show the recipient who has sent the message.

    Change your message if you want Change the message if you want to

    1. <recipient name> <address>
    2. <sender name> <address>
    3. <sender name> is sending you a link

    4. <sender name>

SUPARTZ

  • Click here to contact us

Patient stories

Patient stories
  • See how our products improve patients' lives

Where we operate

Where we operate
  • Where we operate

    Find the Smith & Nephew site nearest you

SUPARTZ JointFluidTherapy

SUPARTZ◊ was the first hyaluronan joint fluid therapy commercially available for human use in treating osteoarthritis. More than 143 million SUPARTZ◊ injections have been sold worldwide since its introduction in 1987. This wealth of clinical experience provides you and your patients with the confidence and reliability you get when you use the world’s most prescribed joint fluid therapy.

SUPARTZ◊ is used for the treatment of pain in osteoarthritis of the knee in patients who have failed to get adequate relief from simple painkillers or from exercise and physical therapy.

SUPARTZ◊ is a solution made of highly purified, sodium hyaluronate (hyaluronan).Hyaluronan is a natural chemical found in the body and is found in particularly high amounts in joint tissues and in the fluid (synovial fluid) that fills the joints. The body’s own hyaluronan acts like a lubricant and shock absorber in synovial fluid of a healthy joint. Osteoarthritis reduces your synovial fluid’s ability to protect and lubricate your joint. A physician administers an injection of SUPARTZ◊ into your knee once a week for 3, 4, or 5 weeks (for up to a total of 5 injections).

Email your postal mailing address to memphis.supartz@smithnephew.com


◊SUPARTZ◊ is a trademark of the Seikagaku Corporation

  • Click here on more information on this product
  • Copyright © 2008 Smith & Nephew
  • Terms of Use